Categories: News

3M M*Modal Fluency for Imaging earns #1 Best in KLAS ranking for Speech Recognition: Front-End, Imaging

ST. PAUL, Minn., Feb. 8, 2022 /PRNewswire/ — 3M M*Modal Fluency for Imaging has been recognized as the Best in KLAS awards 2022 leader in the Speech Recognition Front-End, Imaging category in its annual software and services report.

An artificial intelligence (AI)-powered, complete clinical documentation and workflow management solution for radiologists, 3M Fluency for Imaging combines advanced speech recognition technology, structured reporting and integrated productivity tools for faster creation of higher-quality diagnostic interpretations. It provides real time and proactive insights to radiologists with computer-assisted physician documentation (CAPD) to help ensure complete and compliant documentation. This reporting solution preserves natural workflows, and turns dictation into accurate, electronic documents that are structured, clinically encoded, searchable and shareable.

3M Fluency for Imaging enhances reporting speed and accuracy, streamlines workflows and improves decision-support capabilities to help radiology departments and practices remain competitive and efficient in an ever-evolving regulatory environment,” said Garri Garrison, president of 3M Health Information Systems. “We are extremely proud that our solution earned the 2022 Best in KLAS, Speech Recognition Front-End, Imaging top ranking based on feedback from our clients, who gave us high marks for our overall product quality, service, vendor confidence and value.”

The Best in KLAS annual awards recognize software and services companies that excel in helping health care professionals improve patient care. Rankings are based on feedback from thousands of providers over the previous year. The awards signify top industry vendors’ commitment to and partnerships with the health care IT industry. 

For more information about 3M M*Modal’s top-ranking speech, CDI and radiology reporting solutions, visit www.3M.com/imaging

About 3M

At 3M (NYSE: MMM), we apply science in collaborative ways to improve lives daily as our employees connect with customers all around the world. Learn more about 3M’s creative solutions to global challenges at www.3M.com or on Twitter @3M or @3MNews. 

About KLAS

KLAS is a research and insights firm that works with thousands of health care professionals and clinicians to gather data and insights on software, services and medical equipment. The firm represents the provider and payer voice, and acts as a catalyst for improving vendor performance, highlighting health care industry challenges and opportunities, and helping build understanding and consensus for best practices.

View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-mmodal-fluency-for-imaging-earns-1-best-in-klas-ranking-for-speech-recognition-front-end-imaging-301477082.html

SOURCE 3M

Staff

Recent Posts

Med Holdings Group, Inc. (FKA Yuka Group, Inc.) Announces Acquisition Of Medsmart Wellness Centers, Inc.

DENVER, CO / ACCESSWIRE / March 22, 2024 / (OTC Pink:YUKA) Med Holdings Group, Inc.…

53 mins ago

GE HealthCare Announces Cash Dividend for First Quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a…

4 hours ago

GE HealthCare to Feature Latest Technologies in Interventional Radiology Focused on Precision Care at SIR 2024

Multi-modality showcase brings hands-on experience to care delivery for a wide range of vascular diseases…

4 hours ago

Smartsheet Names Katie Rooney to Board of Directors

Experienced global CFO adds depth in financial strategy and operating excellence to Smartsheet boardBELLEVUE, Wash.--(BUSINESS…

4 hours ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic…

4 hours ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial BOTHELL, Wash. (March…

5 hours ago